Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Capital Lease Obligation

Capital Lease Obligation

9 Months Ended

Sep. 30, 2015

6. Capital Lease Obligation

In 2012, the Company entered into a note agreement in connection with the lease for its Richmond, California facility. The note, for an aggregate principal of $200, with an interest rate of 7%, minimum monthly payments of $4, and a May 31, 2017 maturity, was used to fund leasehold improvements. This note is classified as a component of Capital lease obligation on the balance sheet. Commencing in August 2015, the Company entered into a long-term Capital lease obligation for equipment. The aggregate principal of the lease is $166, with an interest rate of 4.7%, minimum monthly payments of $3 and matures on July 1, 2020. The total capital lease obligation, including a nominal capital lease for equipment, was $169 and $13 as of September 30, 2015, and December 31, 2014, respectively.

Future obligations as of September 30, 2015 are as follows:

	Leasehold
	Improvement			Capital
	Note			Lease			Total
2015 (remainder)	$	12		$	10		$	22
2016		48			42			90
2017		20			40			60
2018		-			37			37
2019		-			37			37
Thereafter		-			22			22
Total minimum payments		80			188			268
Less: interest		(5	)		(19	)		(24	)
Present value minimum payments		75			169			244
Less: current portion		(44	)		(35	)		(79	)
Long-term portion of capital lease obligation	$	31		$	134		$	165